Ключевые слова:
experimental diabetes mellitus, myocardial ischemia, reperfusion, histochemistry, Van Gieson staining, Li staining method, fibrosis, postischemic remodeling.Библиографические ссылки
1. Cheng Y, Wang Y, Yin R, Xu Y, Zhang L, Zhang Y, et al. Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy. Front Endocrinol (Lausanne). 2023;14:1162754. doi:10.3389/fendo.2023.1162754.
2. Dia M, Paccalet A, Pillot B, et al. Myocardial ischemia-reperfusion and diabetes: lessons learned from bedside to bench. Front Cardiovasc Med. 2021;8:660698. doi:10.3389/fcvm.2021. 660698.
3. Duan PH, Li HX, Li JH, et al. Myocardial ischemia reperfusion in diabetes: mechanism of injury and its drug treatment. Diabetol Metab Syndr. 2026;18:71. doi:10.1186/s13098-026-02098-z.
4. Kilic M, Halici Z. Molecular and biological approach to ischemia/reperfusion in diabetes conditions. Mol Biol Rep. 2025;52(1):620. doi:10.1007/s11033-025-10686-x.
5. Lunde IG, Rypdal KB, Van Linthout S, Díez J, González A. Myocardial fibrosis from the perspective of the extracellular matrix: mechanisms to clinical impact. Matrix Biol. 2024;134:1–22. doi:10.1016/j. matbio.2024.08.008.
6. Ma H, Zhao J, Zheng Y, et al. Potential mechanisms of metabolic reprogramming induced by ischemia-reperfusion injury in diabetic myocardium. J Diabetes. 2024;16(10):e70018. doi:10. 1111/1753-0407.70018.
7. Rudokas MW, McKay M, Toksoy Z, et al. Mitochondrial network remodeling of the diabetic heart: implications to ischemia related cardiac dysfunction. Cardiovasc Diabetol. 2024;23(1):261. doi:10.1186/s12933-024-02357-1.
8. Salvador DB Jr, Gamba MR, Gonzalez-Jaramillo N, et al. Diabetes and myocardial fibrosis: a systematic review and meta-analysis. JACC Cardiovasc Imaging. 2022;15(5):796–808. doi:10. 1016/j. jcmg.2021.12.008.
9. Samidurai A, Saravanan M, Ockaili R, et al. Single-dose treatment with rapamycin preserves post-ischemic cardiac function through attenuation of fibrosis and inflammation in diabetic rabbit. Int J Mol Sci. 2023;24(10):8998. doi:10.3390/ijms24108998.
10. Sun J, Zhou R, Liu M, Zhang D. The role of myocardial fibrosis in the diabetic cardiomyopathy. Diabetol Metab Syndr. 2025;17:242. doi:10.1186/s13098-025-01783-9.
11. Xue J, Zhuang J, Wang X, et al. Mechanisms and therapeutic strategies for myocardial ischemia-reperfusion injury in diabetic states. ACS Pharmacol Transl Sci. 2024;7(12):3691–3717. doi:10.1021/acsptsci.4c00272.
12. Yin X, Yin X, Pan X, et al. Post-myocardial infarction fibrosis: pathophysiology, exami-nation, and intervention. Front Pharmacol. 2023;14:1070973. doi:10.3389/fphar.2023.107 0973.
